Literature DB >> 31401722

Assessment of angiogenesis in rabbit orthotropic liver tumors using three-dimensional dynamic contrast-enhanced ultrasound compared with two-dimensional DCE-US.

Qiao Zheng1, Jian-Chao Zhang1, Zhu Wang1, Si-Min Ruan1, Wei Li1, Fu-Shun Pan1, Li-Da Chen1, Yu-Chen Zhang2, Wen-Xin Wu2, Xiao-Yan Xie1, Ming-De Lu1,3, Quan-Yuan Shan4, Wei Wang5.   

Abstract

OBJECTIVES: To evaluate quantitative three-dimensional (3D) dynamic contrast-enhanced ultrasound (DCE-US) in the assessment of tumor angiogenesis using an orthotropic liver tumor model.
METHODS: Nine New Zealand white rabbits with liver orthotropic VX2 tumors were established and imaged by two-dimensional (2D) and 3D DCE-US after SonoVue® bolus injections. The intraclass correlation coefficients of perfusion parameters, including peak intensity (PI), mean transit time, time to peak, and area under the curve, were calculated based on time-intensity curve. The percentage area of microvascular (PAMV) and the expression of vascular endothelial growth factor (VEGF) were both evaluated by immunohistochemical analysis and weighted by the tumor activity area ratio. Correlations between quantitative and histologic parameters were analyzed.
RESULTS: The reproducibility of 3D DCE-US quantitative parameters was excellent (ICC 0.91-0.99); but only PI showed high reproducibility (ICC 0.97) in 2D. None of the parameters of quantitative 2D DCE-US were significantly correlated with weighted PAMV or VEGF. For 3D DCE-US, there was a positive correlation between PI and weighted PAMV (r = 0.74, P = 0.04) as well as VEGF (r = 0.79, P = 0.02).
CONCLUSION: Quantitative parameters of 3D DCE-US show feasibility, higher reproducibility and accuracy for the assessment of tumor angiogenesis using an orthotropic liver tumor model compared with 2D DCE-US.

Entities:  

Keywords:  Assessment; Pathologic neovascularization; Three-dimensional imaging; Ultrasonography

Mesh:

Substances:

Year:  2019        PMID: 31401722     DOI: 10.1007/s11604-019-00861-z

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  33 in total

1.  Evaluation of thyroid cancer in Chinese females with breast cancer by vascular endothelial growth factor (VEGF), microvessel density, and contrast-enhanced ultrasound (CEUS).

Authors:  Xi Wei; Ying Li; Sheng Zhang; Gao Ming
Journal:  Tumour Biol       Date:  2014-04-01

2.  Quantitative Analysis of Contrast-Enhanced Ultrasound Imaging in Invasive Breast Cancer: A Novel Technique to Obtain Histopathologic Information of Microvessel Density.

Authors:  Naoko Mori; Shunji Mugikura; Shoki Takahashi; Koichi Ito; Chiaki Takasawa; Li Li; Minoru Miyashita; Atsuko Kasajima; Yu Mori; Takanori Ishida; Tetsuya Kodama; Kei Takase
Journal:  Ultrasound Med Biol       Date:  2016-12-29       Impact factor: 2.998

3.  Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.

Authors:  Huaijun Wang; Amelie M Lutz; Dimitre Hristov; Lu Tian; Jürgen K Willmann
Journal:  Radiology       Date:  2016-08-04       Impact factor: 11.105

4.  Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.

Authors:  Huaijun Wang; Dimitre Hristov; Jiale Qin; Lu Tian; Jürgen K Willmann
Journal:  Radiology       Date:  2015-05-22       Impact factor: 11.105

5.  Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model.

Authors:  Olivier Lucidarme; Yuko Kono; Jacqueline Corbeil; Sang-Hee Choi; Jean-Louis Golmard; Judith Varner; Robert F Mattrey
Journal:  Radiology       Date:  2006-06       Impact factor: 11.105

6.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

7.  Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.

Authors:  Jianhua Zhou; Huiping Zhang; Huaijun Wang; Amelie M Lutz; Ahmed El Kaffas; Lu Tian; Dimitre Hristov; Jürgen K Willmann
Journal:  Angiogenesis       Date:  2017-07-18       Impact factor: 9.596

8.  Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy.

Authors:  Jian-wei Wang; Long-hui Cao; Feng Han; Wei Zheng; Yao Chen; An-hua Li; Jian-hua Zhou
Journal:  Acta Radiol       Date:  2013-05-12       Impact factor: 1.990

Review 9.  Tumor angiogenesis: review of current applications in tumor prognostication.

Authors:  N Weidner
Journal:  Semin Diagn Pathol       Date:  1993-11       Impact factor: 3.464

10.  Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.

Authors:  Nathalie Lassau; Julia Bonastre; Michèle Kind; Valérie Vilgrain; Joëlle Lacroix; Marie Cuinet; Sophie Taieb; Richard Aziza; Antony Sarran; Catherine Labbe-Devilliers; Benoit Gallix; Olivier Lucidarme; Yvette Ptak; Laurence Rocher; Louis-Michel Caquot; Sophie Chagnon; Denis Marion; Alain Luciani; Sylvaine Feutray; Joëlle Uzan-Augui; Benedicte Coiffier; Baya Benastou; Serge Koscielny
Journal:  Invest Radiol       Date:  2014-12       Impact factor: 6.016

View more
  2 in total

Review 1.  Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics.

Authors:  Florentina Pascale; Jean-Pierre Pelage; Michel Wassef; Saïda H Ghegediban; Jean-Pierre Saint-Maurice; Thierry De Baere; Alban Denys; Rafael Duran; Frédéric Deschamps; Olivier Pellerin; Noboru Maeda; Alexandre Laurent; Julien Namur
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

Review 2.  Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma.

Authors:  Quan Chen; Austin Z Chen; Guorong Jia; Jindian Li; Chuansheng Zheng; Kai Chen
Journal:  Hepatol Commun       Date:  2021-11-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.